In summary, we have shown herein that treatment of allergic mice with rottlerin results in the inhibition of PKC δ and the subsequent disruption of a PI3K/Akt/mTOR/HIF-1α/VEGF module, thereby reversing all pathophysiologic symptoms of asthma. This evidence concerns the gene AKT1 and asthma.